| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,682 |
3,441 |
$692K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,373 |
1,263 |
$688K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,946 |
2,773 |
$394K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
975 |
925 |
$316K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,417 |
2,280 |
$224K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
595 |
562 |
$166K |
| 70450 |
Computed tomography, head or brain; without contrast material |
663 |
635 |
$52K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
95 |
93 |
$33K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
145 |
139 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
257 |
242 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
128 |
122 |
$8K |
| 73564 |
|
68 |
67 |
$7K |
| 76830 |
Ultrasound, transvaginal |
25 |
24 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
1,140 |
1,072 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
19 |
16 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,321 |
2,034 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
176 |
170 |
$931.36 |
| 80053 |
Comprehensive metabolic panel |
2,977 |
2,734 |
$221.71 |
| 93971 |
|
12 |
12 |
$186.55 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
224 |
219 |
$127.23 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,993 |
2,701 |
$126.36 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,048 |
1,846 |
$124.93 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
347 |
323 |
$97.26 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,013 |
3,666 |
$80.98 |
| 73630 |
|
40 |
40 |
$49.62 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,419 |
1,333 |
$38.43 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
839 |
785 |
$36.21 |
| 90715 |
|
24 |
24 |
$30.95 |
| 73130 |
|
41 |
39 |
$23.80 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,415 |
1,297 |
$18.85 |
| 84703 |
|
1,160 |
1,090 |
$10.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,759 |
1,582 |
$1.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
345 |
319 |
$1.10 |
| 81001 |
|
2,994 |
2,761 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
256 |
242 |
$0.00 |
| 83690 |
|
1,886 |
1,715 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
273 |
266 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
321 |
283 |
$0.00 |
| 96376 |
|
487 |
427 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
364 |
318 |
$0.00 |
| 85027 |
|
282 |
264 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
383 |
353 |
$0.00 |
| 85730 |
|
268 |
257 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,142 |
1,061 |
$0.00 |
| 87077 |
|
81 |
68 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
1,124 |
1,059 |
$0.00 |
| 87081 |
|
261 |
257 |
$0.00 |
| 83735 |
|
526 |
492 |
$0.00 |
| 83605 |
|
151 |
127 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
411 |
385 |
$0.00 |
| 84484 |
|
1,412 |
1,164 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
291 |
262 |
$0.00 |
| 87040 |
|
110 |
61 |
$0.00 |
| 85379 |
|
675 |
640 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
199 |
189 |
$0.00 |
| 80320 |
|
76 |
70 |
$0.00 |
| 83880 |
|
44 |
43 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
55 |
51 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$0.00 |
| 81025 |
|
465 |
436 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,869 |
1,650 |
$0.00 |
| 87631 |
|
69 |
68 |
$0.00 |
| 80306 |
|
276 |
256 |
$0.00 |
| 85610 |
|
1,126 |
1,059 |
$0.00 |
| 82248 |
|
1,121 |
1,055 |
$0.00 |
| 73562 |
|
13 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,485 |
1,389 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
322 |
313 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,018 |
865 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
507 |
452 |
$0.00 |
| 73610 |
|
54 |
49 |
$0.00 |
| 73030 |
|
13 |
12 |
$0.00 |
| 85007 |
|
50 |
49 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,810 |
1,562 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
135 |
128 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
26 |
25 |
$0.00 |
| 87400 |
|
700 |
332 |
$0.00 |
| 87186 |
|
43 |
38 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
124 |
118 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$0.00 |